Skip to content

Serotonin: all studies

Page 319 of 408: studies 3,181 to 3,190 of 4,072, newest first. Back to the serotonin overview

Research

Dark Classics in Chemical Neuroscience: Mescaline

ACS Chemical Neuroscience May 30, 2018 Bruce K. Cassels, Patricio Sáez-briones 84 citations

Archeological studies in the United States, Mexico, and Peru suggest that mescaline, as a cactus constituent, has been used for more than 6000 years. Although it is a widespread cactus alkaloid, it is present in high concentrations in few species, notably the North American peyote ( Lophophora williamsii) and the South American wachuma ( Trichocereus pachanoi, T. peruvianus, and T. bridgesii)....

Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report.

Journal of Medical Case Reports May 25, 2018 Kaeley Kaplan, Fiona Kurtz, Kelly Serafini

In this report, we describe a case of a patient with substance-induced anxiety disorder occurring after a single dose of 3,4-methylenedioxymethamphetamine. Furthermore, we describe the use and efficacy of the Primary Care Behavioral Health model, a collaborative approach to integrative primary mental health care, in evaluating and treating this rare mental health disorder. Three days following...

DOI: 10.1186/s13256-018-1670-7 (opens in new tab) Full text (opens in new tab) MDMA 3,4-methylenedioxymethamphetamine Mental health Primary care +1

A Review of the Mechanism of Antagonism of N-methyl-D-aspartate Receptor by Ketamine in Treatment-resistant Depression.

Cureus May 18, 2018 Yasar Sattar, John M Wilson, Ali M Khan et al.

The biochemical processes involved in depression go beyond serotonin, norepinephrine, and dopamine. The N-methyl-D-aspartate (NMDA) receptor has a major role in the neurophysiology of depression. Ketamine, one of the prototypical NMDA antagonists, works rapidly in controlling depressive symptoms, including acutely suicidal behavior, by just a single injection. Ketamine may rapidly increase the...

Pharmacological profile of mephedrone analogs and related new psychoactive substances.

Neuropharmacology May 15, 2018 Dino Luethi, Karolina E. Kolaczynska, Luca Docci et al.

Mephedrone is a synthetic cathinone and one of the most popular recreationally used new psychoactive substances. The aim of the present study was to characterize the in vitro pharmacology of novel analogs of mephedrone and related newly emerged designer stimulants. We determined norepinephrine, dopamine, and serotonin transporter inhibition potencies and monoamine release in...

DOI: 10.1016/j.neuropharm.2017.07.026 (opens in new tab) Full text (opens in new tab) Mephedrone Monoamine New psychoactive substances Receptors +1

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).

Neuropharmacology May 15, 2018 Dino Luethi, Daniel Trachsel, Marius C. Hoener et al. 50 citations

4-Thio-substituted phenethylamines (2C-T drugs) are potent psychedelics with poorly defined pharmacological properties. Because of their psychedelic effects, 2C-T drugs are sometimes sold as new psychoactive substances (NPSs). The aim of the present study was to characterize the monoamine receptor and transporter interaction profiles of a series of 2C-T drugs. We determined the binding...

DOI: 10.1016/j.neuropharm.2017.07.012 (opens in new tab) Full text (opens in new tab) New psychoactive substances Phenethylamines Psychedelics Powerful psychedelic effects +5

Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase‐Enhanced Reactions

Chemistry - A European Journal May 11, 2018 Felix Blei, Florian Baldeweg, Janis Fricke et al. 51 citations

Abstract Psilocybin (4‐phosphoryloxy‐ N , N ‐dimethyltryptamine) is the main alkaloid of the fungal genus Psilocybe , the so‐called “magic mushrooms.” The pharmaceutical interest in this psychotropic natural product as a future medication to treat depression and anxiety is strongly re‐emerging. Here, we present an enhanced enzymatic route of psilocybin production by adding TrpB, the tryptophan...

DOI: 10.1002/chem.201801047 (opens in new tab) Psilocybin Biochemistry Stereochemistry Pharmacology +2

Lysergic Acid Diethylamide and Psilocybin for the Management of Patients with Persistent Pain: a Potential Role?

Pain Management May 1, 2018 Andy Whelan, Mark I Johnson 51 citations

Recently, there has been interest in lysergic acid diethylamide (LSD) and psilocybin for depression, anxiety and fear of death in terminal illness. The aim of this review is to discuss the potential use of LSD and psilocybin for patients with persistent pain. LSD and psilocybin are 5-hydroxytryptamine receptor agonists and may interact with nociceptive and antinociceptive processing. Tentative...

DOI: 10.2217/pmt-2017-0068 (opens in new tab) Full text (opens in new tab) Psychedelics Clinical research Chronic pain Mental health +1

Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination

European Neuropsychopharmacology April 25, 2018 O. Grimm, Rainer Kraehenmann, Katrin H. Preller et al. 94 citations

Recent studies suggest that the antidepressant effects of the psychedelic 5-HT2A receptor agonist psilocybin are mediated through its modulatory properties on prefrontal and limbic brain regions including the amygdala. To further investigate the effects of psilocybin on emotion processing networks, we studied for the first-time psilocybin's acute effects on amygdala seed-to-voxel connectivity...

DOI: 10.1016/j.euroneuro.2018.03.016 (opens in new tab) Psilocybin Amygdala Prefrontal cortex Salience neuroscience +3

Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine

Frontiers in Neuroscience April 23, 2018 Jon G Dean 39 citations

N,N-dimethyltryptamine (DMT) is a powerful serotonergic psychedelic whose exogenous administration elicits striking psychedelic effects in humans. Studies have identified DMT and analogous compounds (e.g., 5-hydroxy-DMT, 5-methoxy-DMT) alongside of an enzyme capable of synthesizing DMT endogenously from tryptamine, indolethylamine-N-methyltransferase (INMT), in human and several other mammalian...

DOI: 10.3389/fnins.2018.00232 (opens in new tab) Endogeny Single-nucleotide polymorphism In vivo Genetics

SLC6A4 binding site and acute prosocial effects of (+/-)-3,4-methylendioxymethamphetamine (MDMA) are evolutionarily conserved in Octopus bimaculoides

bioRxiv Preprint Server April 16, 2018 Eric Edsinger, Gül Dölen 1 citation preprint

Human and octopus lineages are separated by over 500 million years of evolution, and show divergent anatomical patterns of brain organization. Moreover, while humans exhibit highly complex social behaviors, octopuses are thought to be largely asocial and solitary. Despite these differences, growing evidence suggests that ancient neurotransmitter systems are shared across vertebrate and...